news Sept, 2004 Ron Davis receives lifetime achievment award from the Genetics Society of America GSA newsletter 09/2004; pdf, 847kb May 11, 2004 The genome sequence of the fungal pathogen Candida albicans has been finished. February 11, 2004 Ron W. Davis to deliver Herbert A. Sober Lecture in June January 1, 2004 C. neoformans B-3501A genome sequence made publicly available September 9, 2003 Peter Oefner to give 10th Erwin Schrödinger Lecture in 2004 See News Archive

Exploiting the natural synergism between biology and technology

Our center develops new technologies to address important biological questions that otherwise would not be feasible. Our successes can involve improvements to existing technologies or completely new inventions, both of which aim to increase speed and accuracy while decreasing cost. In turn, once a new technology has been developed or advanced, it can often drive the perception of what is possible in the realm of experimental biology. Historically, this synergism between biology and technology has thrived at SGTC as applied to yeast functional genomics and large-scale sequencing efforts. In the next phase of our evolution we will use yeast as the test-bed of advanced technologies to enable novel solutions to the greatest challenges facing human health.